Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Dec 10, 2011; 2(12): 377-383
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.377
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.377
Trial | Phase | Pts | Study design | Main end-point | Results |
Al-Sarraf M et al[18] | III | 147 | Exclusive RT alone vs CCRT followed by cDDP-5FU | 3-year PFS | Experimental arm better (P < 0.01) |
Chen Y et al[19] | III | 316 | Exclusive RT alone vs CCRT followed by cDDP-5FU | 2-year OS | Experimental arm better (P < 0.003) |
Lee AW et al[20] | III | 348 | Exclusive RT alone vs CCRT followed by cDDP-5FU | 5-year PFS | Experimental arm better (P < 0.035) |
Park KH et al[21] | II | 43 | cDDP-5-FU + RT followed by cDDP-Epi-Ble CT | ORR | 100% |
Hu W et al[22] | II | 54 | w Pac + RT followed by cDDP-Pac CT | ORR | 100% |
Leung TW et al[10] | II | 48 | HFRT + cDDP based CT followed by cDDP-5FU CT | 3-year DFS | 71% |
- Citation: Perri F, Bosso D, Buonerba C, Lorenzo GD, Scarpati GDV. Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies. World J Clin Oncol 2011; 2(12): 377-383
- URL: https://www.wjgnet.com/2218-4333/full/v2/i12/377.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i12.377